Oxidized quercetin inhibits α-synuclein fibrillization

α-Synucein is a small (14kDa), abundant, intrinsically disordered presynaptic protein, whose aggregation is believed to be a critical step in Parkinson's disease (PD). Oxidative stress is reported to be a risk factor for dopamine cell degeneration in PD. Flavonoids are suggested to be important...

Full description

Saved in:
Bibliographic Details
Published inBiochimica et biophysica acta Vol. 1830; no. 4; pp. 2872 - 2881
Main Authors Zhu, Min, Han, Shubo, Fink, Anthony L.
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.04.2013
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:α-Synucein is a small (14kDa), abundant, intrinsically disordered presynaptic protein, whose aggregation is believed to be a critical step in Parkinson's disease (PD). Oxidative stress is reported to be a risk factor for dopamine cell degeneration in PD. Flavonoids are suggested to be important antioxidant against oxidative stress. Flavonoids were reported to inhibit fibrillization and disaggregate the preformed fibrils of α-synucein, but the molecular mechanism was still not clear. Quercetin, a well-recognized flavonoid antioxidant, was tested for its inhibition of α-synucein aggregation by thioflavin T assay, light scattering measurement, size-exclusion high performance liquid chromatography, atomic force microscopy, etc. The pre-incubated quercetin exhibited a noticeably stronger inhibition behavior to the fibril formation than that of the freshly prepared. The inhibition is significant in the presence of ortho- and para-benzenediol isomers and inconsiderable in the presence of meta-isomer. The oxidized quercetin species (i.e., chalcantrione, benzyfuranone, quercetinchinone, and other derivatives) cause stronger inhibition than quercetin does because of the elevated polarity and hydrophilicity. Presence of quercetin disaggregates α-synucein fibrils, rather than oligomers and amorphous aggregations. Instead of the antioxidant activity, the 1:1 covalent binding of quercetin with α-synucein, and the increased hydophilicity of the covalently modified α-synucein oligomers or monomers, account for the inhibition of α-synucein fibrillation. Clarification of the molecular mechanism of the inhibition and disaggregation may help to screen safer and more effective flavonoid therapeutic in combating PD. ► Oxidized quercetin inhibits fibrillization of α-synucein more strongly than quercetin does. ► Quercetin disaggregates α-synucein fibrils. ► Quercetin inhibits fibrillization and stabilizes oligomers. ► Quercetin binds with α-synucein in 1:1 ratio. ► Increased hydrophilicity of quercetin and α-synucein adducts accounts for inhibition.
Bibliography:http://dx.doi.org/10.1016/j.bbagen.2012.12.027
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0304-4165
0006-3002
1872-8006
DOI:10.1016/j.bbagen.2012.12.027